The NANOS Annual Meeting Neuro-Ophthalmology Collection: Presentations from the annual meeting of the North American Neuro-Ophthalmology Society (NANOS), a professional organization of more than 600 members who are fully trained ophthalmologists or neurologists. Contains records from the first meeting in 1975 to the present.
NOVEL: https://novel.utah.edu/
TO
1 - 25 of 2
| Title | Creator | Description | Identifier | ||
|---|---|---|---|---|---|
| 1 |
 |
Neuro-ophthalmic Complications in Patients Treated with CTLA-4 and PD-1/PD-L1 Checkpoint Blockade Inhibition (PDF) | Eduardo Nicolás Seleme; Michel Sun; John Chen; Anastasia Zekeridou; Elia Sechi; Ryan Walsh; Johanna Beebe; Osama Sabbagh; Luis Mejico; Sean Gratton; Philip Skidd; David Bellows; Julie Falardeau; Clare Fraser; Cecilia Cappelen-Smith; Scott Haines; Bahareh Hassanzadeh; Meagan Seay; Prem Subramanian; ... | In recent years, the use of CTLA-4 and PD-1/PD-L1 checkpoint blockade inhibitors have proven to be effective and become increasingly widespread treatment options for metastatic melanoma and other cancers by enhancing autologous anti-tumor immune responses. Immune related ophthalmologic complications... | 20200309_nanos_sciplatform1_05-pdf |
| 2 |
 |
Neuro-ophthalmic Complications in Patients Treated with CTLA-4 and PD-1/PD-L1 Checkpoint Blockade Inhibition (Slides) | Eduardo Nicolás Seleme; Michel Sun; John Chen; Anastasia Zekeridou; Elia Sechi; Ryan Walsh; Johanna Beebe; Osama Sabbagh; Luis Mejico; Sean Gratton; Philip Skidd; David Bellows; Julie Falardeau; Clare Fraser; Cecilia Cappelen-Smith; Scott Haines; Bahareh Hassanzadeh; Meagan Seay; Prem Subramanian; ... | In recent years, the use of CTLA-4 and PD-1/PD-L1 checkpoint blockade inhibitors have proven to be effective and become increasingly widespread treatment options for metastatic melanoma and other cancers by enhancing autologous anti-tumor immune responses. Immune related ophthalmologic complications... | 20200309_nanos_sciplatform1_05-slides |
1 - 25 of 2